Keyphrases
BACH1
100%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
72%
DYRK2
60%
Heat Shock Factor 1 (HSF1)
43%
NFE2L2
40%
Transcription Factor
39%
Cannabidiol
30%
In Cancer
28%
Poor Prognosis
25%
Proteotoxic Stress
22%
Cancer Progression
22%
Two-level
22%
Lung Cancer
21%
Methyl
20%
Air Pollutants
20%
CDDO-Me
20%
Antioxidant Response
20%
Bioactivation
20%
Cell Division Cycle 25A
20%
Human Lung Cells
20%
Regulatory Switch
20%
3-Nitrobenzanthrone
20%
Isomeric
20%
Antiviral Pathways
20%
Colorectal Cancer Patients
20%
AT9283
20%
Oncolytic Virotherapy
20%
Stress-responsive
20%
Keratinocytes
20%
Sulforaphane
20%
Inflammatory Pathways
20%
Isothiocyanates
20%
Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A
20%
Kinase Inhibitor
20%
Natural Triterpenoids
20%
Mammalian Target of Rapamycin (mTOR)
20%
Dimethyl Itaconate
20%
Antioxidant Pathway
20%
Acetylenic
20%
Dual Inhibition
20%
Biotinylation
20%
Multi-target
20%
Cancer Signatures
20%
New Inhibitors
20%
Cancer Cells
14%
Therapeutic Outcome
13%
Heme oxygenase-1 (HO-1)
11%
Triple-negative Breast Cancer
9%
Tumor
9%
Oxidative Stress
8%
CDDO Derivatives
8%
Neurodegenerative Diseases
8%
Degrader
7%
Oxidative Inflammation
7%
Transcriptional Repressor
6%
Huntington's Disease
6%
Chemical Derivatives
6%
Heterogeneity in Responses
6%
Tumor Organoids
6%
Tumor Slices
6%
Antiviral Response
6%
Viral Spread
6%
Patient-derived
6%
Anticancer Therapeutics
6%
Type I IFN
6%
Cancer Cell Lines
6%
Treatment Failure
6%
Brain Tumor
6%
Keap1-Nrf2
6%
Cysteine Residues
6%
Three-dimensional (3D)
6%
Itaconate
6%
Resistant Cancer Cells
6%
Antiviral Immunity
6%
Organotypic
6%
Krebs Cycle
6%
Clinical Efficacy
6%
Colon Tumor
6%
Tumor Model
6%
Colon
6%
NF-B
6%
Oncolytic Virus
6%
Cas9 Protein
6%
Proteostasis
5%
HSF1 Inhibitors
5%
Therapeutic Target
5%
Antioxidant Properties
5%
Phytocannabinoids
5%
Lung Cancer Cells
5%
Triple-negative Breast Cancer Cells
5%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
74%
Antioxidant
61%
Prothrombin
41%
Lung Cancer
34%
Proteasome
33%
Cannabidiol
30%
Inflammation
24%
Transcription Factors
22%
Neoplasm
20%
3 Nitrobenzanthrone
20%
Isothiocyanate
20%
Bardoxolone Methyl
20%
Cannabidiol Derivative
20%
Bardoxolone
20%
Mammalian Target of Rapamycin
20%
Sulforaphane
20%
1 Cyclopropyl 3 [3 (5 Morpholinomethyl 1h Benzimidazol 2 Yl) 1h Pyrazol 4 Yl]urea
20%
Bioactivation
20%
Cycline
20%
Cyclin Dependent Kinase
20%
Triterpenoid
20%
Ubiquitin Protein Ligase E3
20%
Ubiquitin
20%
Transcription Factor NF E2 P45 Subunit
20%
Phosphotransferase Inhibitor
20%
Protein Serine Threonine Kinase
20%
Virotherapy
20%
Antivirus Agent
20%
Itaconic Acid
20%
Degenerative Disease
20%
Neuroprotective Agent
20%
Colorectal Carcinoma
20%
Phosphatase
20%
Breast Cancer
20%
Anti-Inflammatory Drug
17%
Phosphotransferase
15%
Protein Kinase B
14%
Heat Shock Transcription Factor 1
13%
Tumor Suppressor Protein
13%
Neuroprotection
10%
Antiinflammatory Activity
10%
Huntington Chorea
10%
Multiple Sclerosis
10%
Alzheimer's Disease
10%
Heme Oxygenase 1
9%
Hemin
6%
Ligase
6%
Protein P53
6%
Pharmaceutical Chemistry
6%
Myeloma
6%
Ovary Cancer
6%
Triple Negative Breast Cancer
6%
Brain Cancer
6%
Tamsulosin
6%
Colon Carcinoma
6%
Liver Cancer
6%
Sickle Cell Anemia
6%
Reperfusion Injury
6%
Colon Tumor
5%
Tumor Model
5%
Cysteine
5%
Oncolytic Virus
5%
Intracranial Tumor
5%
Biochemistry, Genetics and Molecular Biology
Kinase
67%
Phosphotransferase
67%
Cancer Cell
50%
Heat Shock Transcription Factor 1
40%
Colon
30%
Proteasome
23%
Protein Homeostasis
22%
Isothiocyanate
20%
HSF1
20%
Mechanistic Target of Rapamycin
20%
Dual-Specificity Kinase
20%
Tyrosine
20%
Tumor Suppressor Protein
20%
Sulforaphane
20%
Anticancer
20%
Metabolite
20%
Cell Survival
20%
Cell Cycle
20%
BACH1
20%
Protein Kinase B
14%
Oncogene C Myc
10%
Aurora Kinase
10%
Small Molecule
10%
Protein Folding
10%
P53
10%
Antineoplastic Activity
10%
Citric Acid Cycle
10%
Krebs Cycle
10%
KEAP1
10%
Tamsulosin
10%
Cysteine
10%
Transcription Factors
8%
CRISPR/Cas9
6%
Genetics
6%